Position in AMGN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$337,857
+$10,285 QoQ
Shares Held
933
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#2,469
of 3,140 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026INTEGRAL INVESTMENT ADVISORS, INC. holds $11,546,772 across 7 Drug Manufacturers - General names. AMGN ranks #5 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,544 | $5,450,210 | |
| 2 | JNJ |
Johnson & Johnson
|
16,785 | $4,262,886 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
4,577 | $578,258 | |
| 4 | ABBV |
AbbVie Inc.
|
1,545 | $388,783 | |
| 5 | AMGN |
Amgen Inc
This page
|
933 | $337,857 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,159 | $277,431 | |
| 7 | PFE |
Pfizer Inc
|
10,438 | $251,347 |
All Filings in AMGN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $337,857 | 933 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $327,572 | 931 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $351,203 | 1,073 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $261,317 | 926 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $257,710 | 923 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $291,299 | 935 | Shares | Sole | 2025-04-15 | |
| No filing history on record for this holder in this stock. | ||||||